Welcome
Meet the Team
Clinical Research Group
Clinical Trials Program
Information for Companies
Information for the Public
What are Clinical Trials?
Clinical Research Resources & Links
Information for Researchers and Staff
University Laboratory Animal Resources (ULAR)
Resources for Researchers
Research Committee College of Medicine
Research Administration & Scientific Affairs
Research Departments, Centers, and Institutes
Biomedical Graduate Studies
Office of Medical Student Research
Research Portal

Menu Font Size

What are Clinical Trials?

A clinical trial, also called clinical research, is a study performed with people who have volunteered to help answer a specific health question. For example, a clinical trial might determine whether a certain drug or treatment prevents a particular disease or condition. 


          Learn more about clinical trials:


 

What Are the Different Types of Clinical Trials?

 
There are five different types of clinical trials. Each type focuses on a different aspect of medical treatment.  

  Treatment Trials:


Treatment trials test experimental drugs, procedures and other treatment. 
 

  Prevention Trials:


Prevention clinical trials focus on disease prevention.  

  Diagnostic Trials:


Diagnostic clinical trials focus on finding better ways diagnose and evaluate a specific disease or condition. 
 

  Screening Trials:

 
Screening clinical trials focus on better identifying and detecting diseases and conditions. 
 

 Quality of Life Trials:

 
Quality of life clinical trials focus on ways to better quality of life for people with chronic diseases or conditions.


 Clinical Trials are conducted in four phases. Each phase has a different purpose and answers different questions.

 Phase 1:  


In Phase I clinical trials, an experimental drug or treatment is tested on a small group, usually 20-80 people, to ascertain its safety, determine a safe dose and identify side effects.

 Phase 2:  


In Phase II clinical trials, researchers of the study further test the experimental drug or treatment in a larger group, usually 100-300 people, to evaluate its effectiveness and further ascertain its safety.

 Phase 3:  

 
In Phase III clinical trials, the experimental drug or treatment is tested on a much larger group, usually 1,000-3,000 people, to validate its effectiveness, examine side effects, collect further data and compare the treatment or drug to current standard treatments. In the comparison, one part of the group will receive the experimental drug or treatment, while the other part of the group will receive a standard treatment or a placebo (a treatment that has no effect), in a randomized manner.

 Phase 4:  


After the drug or treatment is approved by the U.S. Food and Drug Administration (FDA), Phase IV clinical trials (also known as post-marketing studies) may be conducted to collect more information, including risks, benefits, and the best usage method.

Back to Top

 


How Are Clinical Trials Funded?

Clinical trials are funded (or sponsored) by an array of institutions, individuals and organizations, such as physicians, medical institutions, medical academic centers, foundations, pharmaceutical companies and governmental agencies. The National Institutes of Health (NIH), the Department of Defense (DoD), and the Department of Veterans Affairs (VA) are examples of governmental agencies that sponsor clinical trials.

Clinical tirals can be conducted in various places including hospitals, universities, medical offices, community clinics and research clinics.

Back to Top


Who Participates in Clinical Trials? What Is Informed Consent?

Participation in a clinical trial is voluntary. At any time, a participant can change her/his mind and withdraw from the clincial trial.

Before a person can participate in a clinical trial, s/he must provide the researcher with consent. Such consent must only by given after the person fully understands the clincial trial. Informed consent is the process by which a person learns key details about a clinical trial before s/he decides whether or not to participate. During this process, doctors and research coordinators (usually nurses) will describe the details of the clinical trial such as its purpose, duration, required procedures and visits, key personnel and contacts, as well as risks and benefits of the experimental drug or treatment. All of this information is contained in a document (commonly known as the informed consent form). Once this information is explained, the person will decide to participate or not. If s/he accepts, the document is signed to memorialize her/his informed consent. The informed consent form is not a contract. At any time, a participant can stop her/his participation and withdraw from the clinical trial. 
 
Back to Top 



Who Can Participate in Clinical Trials?

Each clinical trial contains guidelines about who can and cannot participate. These guidelines are maintained to ensure the safety of participants of the clinical trial as well as potential participants. They are also used to ensure that the purpose of the study is effectively answered. These guidelines are never used to personally reject a person from the clinical trial. Each clinical trial will clearly state both inclusion and exclusion criteria. Inclusion criteria are a list of the factors permitting someone to participate. Exclusion criteria are a list of the factors that will disqualify a person from participation. Thus, in order to participate, a person must have all the factors listed in the inclusion criteria and not have any of the factors in the exclusion criteria. Both sets of criteria may contain factors based on age, gender, ethnicity, disease or condition (or lack of), fertility and other health factors.
 
Back to Top



What Are the Benefits and Risks?


The benefits of a well-designed clinical trial are:
  • May gain access to new research treatment that may not be widely available.
  • May obtain expert medical care at leading medical centers.
  • Contribution to medical research and future medical treatments.
The risks of participating in a clinical trial are:
  • Unpleasant, serious and even life-threatening side effects.
  • Treatment may not be effective.
  • Participation may require more time and attention than receiving standard care (e.g. travel to the research site, additional tests or treatments, hospital stays, complex dosage).
Because of the above factors, it is important that a person provide his or her informed consent to a researcher before participation.

 
Back to Top

 

 

You are leaving the Drexel University College of Medicine website

By clicking on this link, you will be leaving the Drexel University College of Medicine–maintained website and entering another website that is not owned, operated, or controlled by Drexel University College of Medicine.

By linking to this external website, Drexel University College of Medicine does not endorse or verify the external website’s content, opinions, products, services, or privacy or security policies.